title: Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment.
authors: Yang
authors: Y
authors: Huang
authors: Fang
authors: F
authors: Cheng
authors: Xiaoyu
authors: X
authors: Zhang
authors: Jianping
authors: J
authors: Tang
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D000069283:Rituximab; D012446:Sacroiliac Joint / Q000473:pathology*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000473:pathology*; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab